Formycon Signs APAC Eylea Biosimilar Deal With Taiwan’s Lotus

The Aflibercept Deal Follows A Flurry Of Approvals In The Past Year

 
• By Adam Zamecnik
  
APAC
join Scrip's APAC regional team for a video overview of recent industry topics and trends • Source: Shutterstock

More from Deals

More from Generics Bulletin